Ascendis Pharma
ASND
ASND
159 hedge funds and large institutions have $5.64B invested in Ascendis Pharma in 2023 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 53 increasing their positions, 63 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.33% less ownership
Funds ownership: 106.81% → 105.48% (-1.3%)
16% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 63
24% less call options, than puts
Call options by funds: $17.4M | Put options by funds: $23M
Holders
159
Holding in Top 10
11
Calls
$17.4M
Puts
$23M
Top Buyers
| 1 | +$16.6M | |
| 2 | +$16.2M | |
| 3 | +$16M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$12M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$8.88M |
Top Sellers
| 1 | -$47.4M | |
| 2 | -$39.3M | |
| 3 | -$21.3M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$15.2M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$11.9M |